Western governments and agencies must share their resources with local scientists conducting HIV research in such developing countries as Uganda say researchers from Imperial College London (medicalnewstoday.com, 10/23).
In a commentary published today in the journal Nature Immunology, researchers argue that more cutting-edge laboratories are needed to conduct HIV-vaccine trials and develop treatment in impoverished nations.
“Old fashioned ‘parachute science’—where scientists from the developed world flew in, bled a few patients and immediately returned to their country of origin with their samples—are no longer required or acceptable,” says Professor Frances Gotch, one of the authors of the commentary. “In-house development and research is an effective and efficient way forward.”